$ENOV
Enovis CORP

2024 Q3 Form 10-Q Financial Statement

#000142080024000022 Filed on August 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2023 Q2
Revenue $505.2M $525.2M $428.5M
YoY Change 21.0% 22.56% -58.13%
Cost Of Revenue $218.8M $236.3M $180.1M
YoY Change 25.32% 31.16% -69.63%
Gross Profit $286.5M $288.9M $248.4M
YoY Change 17.9% 16.32% -42.27%
Gross Profit Margin 56.7% 55.01% 57.96%
Selling, General & Admin $249.9M $264.1M $193.4M
YoY Change 22.33% 36.52% -47.63%
% of Gross Profit 87.22% 91.42% 77.89%
Research & Development $20.49M $23.48M $18.92M
YoY Change 2.96% 24.11% -22.47%
% of Gross Profit 7.15% 8.13% 7.62%
Depreciation & Amortization $71.23M $65.76M $53.04M
YoY Change 28.43% 23.98% -19.66%
% of Gross Profit 24.86% 22.76% 21.36%
Operating Expenses $270.3M $287.6M $244.6M
YoY Change 20.61% 17.56% -37.88%
Operating Profit -$31.74M -$44.22M $3.743M
YoY Change 54.88% -1281.38% -92.95%
Interest Expense $11.07M $16.97M -$4.076M
YoY Change 91.85% -516.32% -127.0%
% of Operating Profit -108.9%
Other Income/Expense, Net $202.0K $33.84M -$753.0K
YoY Change -73.32% -4593.49%
Pretax Income -$42.60M -$27.35M -$19.32M
YoY Change 67.04% 41.55% -150.82%
Income Tax -$9.096M -$8.908M -$4.713M
% Of Pretax Income
Net Earnings -$31.52M -$18.64M -$9.995M
YoY Change 994.48% 86.47% -161.32%
Net Earnings / Revenue -6.24% -3.55% -2.33%
Basic Earnings Per Share -$0.58 -$0.34 -$0.18
Diluted Earnings Per Share -$0.58 -$0.34 -$0.18
COMMON SHARES
Basic Shares Outstanding 55.85M shares 54.85M shares 54.50M shares
Diluted Shares Outstanding 55.67M shares 54.86M shares 54.51M shares

Balance Sheet

Concept 2024 Q3 2024 Q2 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $35.43M $35.00M $32.49M
YoY Change 10.26% 7.73% -95.09%
Cash & Equivalents $35.43M $35.00M $32.49M
Short-Term Investments
Other Short-Term Assets $112.2M $87.43M $101.9M
YoY Change 148.49% -14.18% 11.28%
Inventory $609.7M $615.0M $453.9M
Prepaid Expenses $45.59M $40.55M $26.76M
Receivables $400.2M $394.7M $299.0M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.203B $1.173B $887.2M
YoY Change 40.84% 32.18% -62.21%
LONG-TERM ASSETS
Property, Plant & Equipment $403.3M $378.4M $322.5M
YoY Change 54.98% 17.35% -36.09%
Goodwill $2.394B $2.353B $2.034B
YoY Change 18.08% 15.7% -40.88%
Intangibles $1.396B $1.380B $1.111B
YoY Change 26.84% 24.26% -32.15%
Long-Term Investments
YoY Change
Other Assets $90.32M $88.65M $88.78M
YoY Change -4.87% -0.15% -76.31%
Total Long-Term Assets $4.347B $4.269B $3.556B
YoY Change 22.57% 20.05% -42.04%
TOTAL ASSETS
Total Short-Term Assets $1.203B $1.173B $887.2M
Total Long-Term Assets $4.347B $4.269B $3.556B
Total Assets $5.550B $5.442B $4.444B
YoY Change 26.11% 22.47% -47.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $158.0M $159.8M $147.2M
YoY Change 26.37% 8.6% -72.63%
Accrued Expenses $352.2M $343.1M $182.2M
YoY Change 52.96% 88.28% -62.81%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $20.03M $15.03M $0.00
YoY Change -100.0%
Total Short-Term Liabilities $530.2M $518.0M $353.7M
YoY Change 49.24% 46.46% -75.61%
LONG-TERM LIABILITIES
Long-Term Debt $1.325B $1.329B $400.0M
YoY Change 235.55% 232.36% -75.73%
Other Long-Term Liabilities $313.8M $255.2M $239.1M
YoY Change 96.44% 6.73% -60.21%
Total Long-Term Liabilities $1.639B $1.585B $639.1M
YoY Change 195.5% 147.94% -71.58%
TOTAL LIABILITIES
Total Short-Term Liabilities $530.2M $518.0M $353.7M
Total Long-Term Liabilities $1.639B $1.585B $639.1M
Total Liabilities $2.217B $2.153B $994.9M
YoY Change 131.12% 116.41% -74.09%
SHAREHOLDERS EQUITY
Retained Earnings $420.3M $451.8M $542.4M
YoY Change -22.09% -16.7% -10.21%
Common Stock $56.00K $55.00K $55.00K
YoY Change 1.82% 0.0% 1.85%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.330B $3.286B $3.449B
YoY Change
Total Liabilities & Shareholders Equity $5.550B $5.442B $4.444B
YoY Change 26.11% 22.47% -47.62%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2023 Q2
OPERATING ACTIVITIES
Net Income -$31.52M -$18.64M -$9.995M
YoY Change 994.48% 86.47% -161.32%
Depreciation, Depletion And Amortization $71.23M $65.76M $53.04M
YoY Change 28.43% 23.98% -19.66%
Cash From Operating Activities $53.56M $7.773M $28.10M
YoY Change 72.69% -72.34% -294.85%
INVESTING ACTIVITIES
Capital Expenditures $51.19M $39.41M $36.81M
YoY Change 89.37% 7.06% 52.79%
Acquisitions
YoY Change
Other Investing Activities -$7.232M -$1.921M -$94.80M
YoY Change -172.87% -97.97% 755.81%
Cash From Investing Activities -$58.42M -$41.33M -$131.6M
YoY Change 241.5% -68.6% 274.23%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -148.0K 2.509M 114.2M
YoY Change -98.92% -97.8% -1155.67%
NET CHANGE
Cash From Operating Activities 53.56M 7.773M 28.10M
Cash From Investing Activities -58.42M -41.33M -131.6M
Cash From Financing Activities -148.0K 2.509M 114.2M
Net Change In Cash -5.012M -31.04M 10.71M
YoY Change -2568.97% -389.78% -118.51%
FREE CASH FLOW
Cash From Operating Activities $53.56M $7.773M $28.10M
Capital Expenditures $51.19M $39.41M $36.81M
Free Cash Flow $2.368M -$31.63M -$8.702M
YoY Change -40.53% 263.5% -77.4%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Profit Loss
ProfitLoss
-32971000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3449801000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
10584000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
10322000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3450760000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
44832000 usd
CY2024Q2 us-gaap Derivative Asset Statement Of Financial Position Extensible Enumeration
DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#OtherAssetsCurrent
CY2023Q4 us-gaap Derivative Asset Statement Of Financial Position Extensible Enumeration
DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#OtherAssetsCurrent
CY2023Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
0.09
CY2023Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
0.09
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.34
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.34
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.61
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.61
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
54597142 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
54597142 shares
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-23158000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
0 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
8044000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3445271000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-9813000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-1781000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4980000 usd
us-gaap Profit Loss
ProfitLoss
-90353000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
139167000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
105033000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
5555000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
14102000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
16981000 usd
cfx Noncashinterestexpense
Noncashinterestexpense
2558000 usd
cfx Noncashinterestexpense
Noncashinterestexpense
1481000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-20068000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 usd
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-11123000 usd
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
0 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-19412000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-107000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-383000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-533000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
24807000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
25912000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1953000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
10476000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-6744000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
8324000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
41840000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
27326000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-28383000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
35560000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
76333000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
67248000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
758190000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
98740000 usd
us-gaap Payments For Derivative Instrument Investing Activities
PaymentsForDerivativeInstrumentInvestingActivities
4645000 usd
us-gaap Payments For Derivative Instrument Investing Activities
PaymentsForDerivativeInstrumentInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-839168000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-165988000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
400000000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
15000000 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
219468000 usd
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
940000000 usd
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
370000000 usd
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
446479000 usd
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
11538000 usd
cfx Proceeds From Distribution Spinoff
ProceedsFromDistributionSpinoff
-703000 usd
cfx Proceeds From Distribution Spinoff
ProceedsFromDistributionSpinoff
0 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
4772000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
1177000 usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
1385000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-7174000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-1668000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
867049000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
138711000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-906000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-87000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1408000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8196000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
44832000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
24295000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
43424000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
32491000 usd
us-gaap Stock Issued1
StockIssued1
107877000 usd
us-gaap Stock Issued1
StockIssued1
0 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
us-gaap Use Of Estimates
UseOfEstimates
The Company makes certain estimates and assumptions in preparing its Condensed Consolidated Financial Statements in accordance with GAAP. These estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities as of the date of the Condensed Consolidated Financial Statements, and the reported amounts of revenues and expenses for the periods presented. Actual results may differ from those estimates.
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35004000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36191000 usd
CY2024Q2 us-gaap Restricted Cash
RestrictedCash
8420000 usd
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
8641000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
43424000 usd
CY2024Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
20400000 usd
us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
0 usd
us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
0 usd
cfx Equity Securities Without Readily Determinable Fair Value Number Of Investments
EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments
1 investment
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
525160000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
428502000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1041426000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
834653000 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
9731000 usd
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
3374000 usd
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
1471000 usd
cfx Financing Receivable Allowance For Credit Loss Other Net
FinancingReceivableAllowanceForCreditLossOtherNet
3417000 usd
cfx Financing Receivable Allowancefor Credit Loss Foreign Currency Translation1
FinancingReceivableAllowanceforCreditLossForeignCurrencyTranslation1
-198000 usd
CY2024Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
14853000 usd
CY2024Q2 cfx Net Incomefromcontinuingoperationsattributableto Parent
NetIncomefromcontinuingoperationsattributabletoParent
-18570000 usd
CY2023Q2 cfx Net Incomefromcontinuingoperationsattributableto Parent
NetIncomefromcontinuingoperationsattributabletoParent
-14792000 usd
cfx Net Incomefromcontinuingoperationsattributableto Parent
NetIncomefromcontinuingoperationsattributabletoParent
-90568000 usd
cfx Net Incomefromcontinuingoperationsattributableto Parent
NetIncomefromcontinuingoperationsattributabletoParent
-37830000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54855810 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54510688 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54772231 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54418554 shares
CY2024Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.34
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.27
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-1.65
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.70
CY2024Q2 cfx Net Incomefromcontinuingoperationsattributableto Parent
NetIncomefromcontinuingoperationsattributabletoParent
-18570000 usd
CY2023Q2 cfx Net Incomefromcontinuingoperationsattributableto Parent
NetIncomefromcontinuingoperationsattributabletoParent
-14792000 usd
cfx Net Incomefromcontinuingoperationsattributableto Parent
NetIncomefromcontinuingoperationsattributabletoParent
-90568000 usd
cfx Net Incomefromcontinuingoperationsattributableto Parent
NetIncomefromcontinuingoperationsattributabletoParent
-37830000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54855810 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54510688 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54772231 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54418554 shares
CY2024Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54855810 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54510688 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54772231 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54418554 shares
CY2024Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.34
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.27
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-1.65
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.70
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1378308 shares
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1231504 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1106763 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1154108 shares
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-27352000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-19323000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-106597000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-49282000 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-8908000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4713000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-16312000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-11826000 usd
CY2024Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.326
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.244
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.153
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.240
CY2024Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
100000000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-69630000 usd
us-gaap Translation Adjustment For Net Investment Hedge Increase Decrease Net Of Tax
TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax
18207000 usd
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-51423000 usd
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
426000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-51849000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
21863000 usd
us-gaap Translation Adjustment For Net Investment Hedge Increase Decrease Net Of Tax
TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax
-5449000 usd
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
16414000 usd
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
882000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
15532000 usd
CY2024Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
103992000 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
88129000 usd
CY2024Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
51516000 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
39310000 usd
CY2024Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
540753000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
406931000 usd
CY2024Q2 us-gaap Inventory Gross
InventoryGross
696261000 usd
CY2023Q4 us-gaap Inventory Gross
InventoryGross
534370000 usd
CY2024Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
81224000 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
65538000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
615037000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
468832000 usd
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
1344455000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
466164000 usd
CY2024Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
15028000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 usd
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1329427000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
466164000 usd
CY2024Q2 cfx Letters Of Credit And Surety Bonds Outstanding Amount
LettersOfCreditAndSuretyBondsOutstandingAmount
34100000 usd
CY2024Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
2900000 usd
CY2024Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
15700000 usd
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
95354000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5972000 usd
CY2024Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
71797000 usd
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
70979000 usd
CY2024Q2 us-gaap Accrued Sales Commission Current And Noncurrent
AccruedSalesCommissionCurrentAndNoncurrent
30686000 usd
CY2023Q4 us-gaap Accrued Sales Commission Current And Noncurrent
AccruedSalesCommissionCurrentAndNoncurrent
28539000 usd
CY2024Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
22295000 usd
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
21568000 usd
CY2024Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
16909000 usd
CY2023Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
14384000 usd
CY2024Q2 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
13769000 usd
CY2023Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
14464000 usd
CY2024Q2 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
7453000 usd
CY2023Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
13037000 usd
CY2024Q2 cfx Customeradvancesandbillinginexcessofcostsincurred
Customeradvancesandbillinginexcessofcostsincurred
6704000 usd
CY2023Q4 cfx Customeradvancesandbillinginexcessofcostsincurred
Customeradvancesandbillinginexcessofcostsincurred
6944000 usd
CY2024Q2 cfx Accrued Freight
AccruedFreight
5258000 usd
CY2023Q4 cfx Accrued Freight
AccruedFreight
3909000 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4336000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3765000 usd
CY2024Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
3892000 usd
CY2023Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
278000 usd
CY2024Q2 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
3479000 usd
CY2023Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
2953000 usd
CY2024Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2960000 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2959000 usd
CY2024Q2 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
2665000 usd
CY2023Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
2276000 usd
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
55588000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
45105000 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
343145000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
237132000 usd
CY2023Q4 us-gaap Restructuring Reserve
RestructuringReserve
2276000 usd
cfx Restructuring Settlementand Impairment Provisionsbeforenoncashcharges
RestructuringSettlementandImpairmentProvisionsbeforenoncashcharges
11943000 usd
us-gaap Payments For Restructuring
PaymentsForRestructuring
11570000 usd
us-gaap Restructuring Reserve Translation Adjustment
RestructuringReserveTranslationAdjustment
16000 usd
CY2024Q2 us-gaap Restructuring Reserve
RestructuringReserve
2665000 usd
cfx Noncashimpairmentrestructuringprovisions
Noncashimpairmentrestructuringprovisions
5555000 usd
us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
17498000 usd
CY2024Q2 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
1385200000 usd
CY2023Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
573200000 usd
CY2024Q2 cfx Number Of Contingent Consideration Arrangements Unlimited Based On Percentage Of Sales In Excess Of Benchmark
NumberOfContingentConsiderationArrangementsUnlimitedBasedOnPercentageOfSalesInExcessOfBenchmark
1 contingentconsideration
CY2024Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-33500000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-20100000 usd
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
26025000 usd
cfx Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability Additions
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiabilityAdditions
108977000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-20068000 usd
cfx Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability Interest Charges
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiabilityInterestCharges
0 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
6281000 usd
cfx Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability Foreign Exchange Gain Loss
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiabilityForeignExchangeGainLoss
333000 usd
CY2024Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
108320000 usd
CY2024Q2 us-gaap Payments For Derivative Instrument Investing Activities
PaymentsForDerivativeInstrumentInvestingActivities
4600000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Investment Hedge Gain Loss Reclassification Before Tax
OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
-9252000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Investment Hedge Gain Loss Reclassification Before Tax
OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
-7189000 usd
us-gaap Other Comprehensive Income Loss Net Investment Hedge Gain Loss Reclassification Before Tax
OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
23484000 usd
us-gaap Other Comprehensive Income Loss Net Investment Hedge Gain Loss Reclassification Before Tax
OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
-7189000 usd
CY2024Q2 us-gaap Derivative Assets
DerivativeAssets
10937000 usd
CY2023Q4 us-gaap Derivative Assets
DerivativeAssets
34804000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
525160000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
428502000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1041426000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
834653000 usd
CY2024Q2 cfx Segment Operating Income
SegmentOperatingIncome
90214000 usd
CY2023Q2 cfx Segment Operating Income
SegmentOperatingIncome
65682000 usd
cfx Segment Operating Income
SegmentOperatingIncome
173448000 usd
cfx Segment Operating Income
SegmentOperatingIncome
122093000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-27352000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-19323000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-106597000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-49282000 usd
CY2024Q2 cfx Restructuring Chargesand Other Related Charges
RestructuringChargesandOtherRelatedCharges
4587000 usd
CY2023Q2 cfx Restructuring Chargesand Other Related Charges
RestructuringChargesandOtherRelatedCharges
3806000 usd
cfx Restructuring Chargesand Other Related Charges
RestructuringChargesandOtherRelatedCharges
17498000 usd
cfx Restructuring Chargesand Other Related Charges
RestructuringChargesandOtherRelatedCharges
6742000 usd
CY2024Q2 cfx Medical Device Regulations And Other Costs
MedicalDeviceRegulationsAndOtherCosts
4542000 usd
CY2023Q2 cfx Medical Device Regulations And Other Costs
MedicalDeviceRegulationsAndOtherCosts
8997000 usd
cfx Medical Device Regulations And Other Costs
MedicalDeviceRegulationsAndOtherCosts
9460000 usd
cfx Medical Device Regulations And Other Costs
MedicalDeviceRegulationsAndOtherCosts
16793000 usd
CY2024Q2 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
22693000 usd
CY2023Q2 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
5435000 usd
us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
43530000 usd
us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
17065000 usd
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7641000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8868000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14041000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15776000 usd
CY2024Q2 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
30127000 usd
CY2023Q2 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
20794000 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
57300000 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
40745000 usd
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
40936000 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
32249000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
81867000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
64289000 usd
CY2024Q2 cfx Inventory Adjustments Increase Decrease
InventoryAdjustmentsIncreaseDecrease
23908000 usd
CY2023Q2 cfx Inventory Adjustments Increase Decrease
InventoryAdjustmentsIncreaseDecrease
27000 usd
cfx Inventory Adjustments Increase Decrease
InventoryAdjustmentsIncreaseDecrease
28985000 usd
cfx Inventory Adjustments Increase Decrease
InventoryAdjustmentsIncreaseDecrease
146000 usd
CY2024Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-16969000 usd
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-4076000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-36965000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-9728000 usd
CY2024Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
33836000 usd
CY2023Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-753000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
9601000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-92000 usd
CY2024Q2 cfx Segment Operating Income
SegmentOperatingIncome
90214000 usd
CY2023Q2 cfx Segment Operating Income
SegmentOperatingIncome
65682000 usd
cfx Segment Operating Income
SegmentOperatingIncome
173448000 usd
cfx Segment Operating Income
SegmentOperatingIncome
122093000 usd
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001420800-24-000022-index-headers.html Edgar Link pending
0001420800-24-000022-index.html Edgar Link pending
0001420800-24-000022.txt Edgar Link pending
0001420800-24-000022-xbrl.zip Edgar Link pending
cfx-20240628.htm Edgar Link pending
cfx-20240628.xsd Edgar Link pending
exhibit211subsidiariesofth.htm Edgar Link pending
exhibit311ceocertification.htm Edgar Link pending
exhibit312cfocertification.htm Edgar Link pending
exhibit321ceocertification.htm Edgar Link pending
exhibit322cfocertification.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
cfx-20240628_cal.xml Edgar Link unprocessable
cfx-20240628_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cfx-20240628_lab.xml Edgar Link unprocessable
cfx-20240628_pre.xml Edgar Link unprocessable
cfx-20240628_htm.xml Edgar Link completed
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending